サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1235982

女性用ヘルスケアの世界市場規模調査・予測：医薬品別、用途別、地域別分析、2022-2029年

Global Womens Healthcare Market Size study & Forecast, by Drugs, Application and Regional Analysis, 2022-2029
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
女性用ヘルスケアの世界市場規模調査・予測：医薬品別、用途別、地域別分析、2022-2029年
出版日: 2023年03月06日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の女性用ヘルスケア市場は、2021年に約123億米ドルと評価され、2022年から2029年にかけて13.2%以上の健全な成長率で成長すると予測されています。

女性用ヘルスケアは、女性の身体的および精神的な幸福に影響を与える病気や状態の治療と診断を扱う医学の一分野として定義されています。女性用ヘルスケアには、避妊、性感染症（STI）、乳がん、卵巣がん、マンモグラフィー、更年期障害、骨粗鬆症、妊娠・出産関連問題、性の健康など、幅広い分野が含まれます。女性の慢性的な健康状態の増加や、意図しない妊娠を防ぐための避妊具の普及が、市場成長を促す主な要因となっています。

女性の慢性的な健康状態の増加は、世界の女性用ヘルスケア市場の成長に寄与しています。例えば、世界保健機関の推計によると、2020年現在、世界全体で約4,800万組の夫婦と1億8,600万人の個人が不妊症の影響を受けているとされています。また、National Survey of Family Growth（NSFG）の調査によると、妊娠を希望する女性の約15.5％が不妊症に悩まされているとされています。さらに、望まない妊娠を防ぐための避妊具の消費量が増加していることも、市場を牽引する要因となっています。例えば、世界保健機関（WHO）によると、2020年の時点で、現代的な避妊方法を利用している女性は、10年前の6億6,300万人から8億5,100万人に増え、普及率は47.7%から49.0%に上昇しました。2030年には、さらに7,000万人の女性が人口に加わると予想されています。また、人口増加を抑制するための政府当局の取り組みや新製品開発への注目が高まっており、予測期間中、市場に有利な成長見通しをもたらすでしょう。しかし、女性用ヘルスケア製品のコストが高く、中低所得者層における認知度の低さが、2022-2029年の予測期間を通じて市場成長の妨げとなります。

女性用ヘルスケアの世界市場調査において考慮した主要地域は、アジア太平洋地域、北米、欧州、ラテンアメリカ、その他の地域です。北米は、ブランド製品の優位性と、PCOSと閉経後骨粗鬆症の有病率の増加、初回妊娠の中央年齢の上昇、米国とカナダにおけるヘルスケア費用の増加により、収益面で市場を独占しています。一方、アジア太平洋地域は、避妊薬の消費量の増加、女性における慢性疾患の有病率の増加などの要因により、予測期間中に最も高いCAGRで成長すると予想され、市場にとって有利な機会を提供します。例えば-2021年にNational Family Health Survey（NFHS）が実施した調査によると、インドでは家族計画のための現代の避妊薬の使用率は、NFHS-4（2015-16）とNHFS-5（2019-20）の調査の間に47.8％から56.5％に増加しました。

最近の市場動向

  • 2021年4月、FDAは、3mgのドロスピレノン（DRSP）と14.2mgのエステトロール（E4）を含む新しい複合経口避妊薬（COC）である本剤を承認しました。ミスラ・ファーマシューティカルズは、E4を含む最初で唯一の避妊用ピルを作りました。これは、米国で50年以上ぶりに導入された新しいエストロゲンとなります。
  • 2022年7月、フランスの製薬会社HRAファーマが米国食品医薬品局（FDA）に申請し、同国初の市販の避妊用ピルが誕生しました。

世界市場レポートの範囲

  • 過去データ：2019-2020-2021年
  • 推計の基準年：2021年
  • 予測期間：2022-2029年
  • レポート範囲：収益予測、企業ランキング、競合情勢、成長要因、動向
  • 地域別範囲：北米、欧州、アジア太平洋地域、ラテンアメリカ、世界のその他地域
  • カスタマイズの範囲：レポートカスタマイズ（最大8名分の作業時間）を無料で提供。国別、地域別、セグメント別範囲の追加・変更。

本調査の目的は、近年における様々な分野・国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国の産業の質的・量的な側面を取り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢などの詳細な分析とともに、利害関係者が投資するためのミクロ市場での潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

  • マーケットスナップショット
  • 世界・セグメント別市場推定・予測、2019年～2029年
    • 女性用ヘルスケア市場、地域別、2019-2029年
    • 女性用ヘルスケア市場、医薬品別、2019-2029年
    • 女性用ヘルスケア市場、用途別、2019年～2029年
  • 主な動向
  • 調査手法
  • 調査の前提条件

第2章 女性用ヘルスケアの世界市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 調査対象範囲
    • 産業の進化
  • 本調査の対象となった年
  • 通貨換算レート

第3章 女性用ヘルスケアの世界市場力学

  • 女性用ヘルスケア市場のインパクト分析（2019年～2029年）
    • 市場促進要因
      • 女性の慢性的な健康状態の発生率の増加
      • 意図しない妊娠を防ぐための避妊具の普及が進む
    • 市場の課題
      • 女性用ヘルスケア製品の高額な費用
      • 中低所得者層における認知度の低さ
    • マーケットオポチュニティ
      • 新製品開発への注目度上昇
      • 人口増加抑制のための政府当局の取り組み

第4章 世界の女性用ヘルスケア市場の産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
  • PEST分析
    • 政治的
    • 経済的
    • ソーシャル
    • テクニカル
  • 最高の投資機会
  • 主要成功戦略
  • 業界関係者見通し
  • アナリストの提言と結論

第5章 リスクアセスメント：COVID-19の影響

  • COVID-19が業界に与える全体的な影響についての評価
  • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 女性用ヘルスケアの世界市場：医薬品別

  • マーケットスナップショット
  • 女性用ヘルスケアの世界市場：医薬品別、性能- ポテンシャル分析
  • 女性用ヘルスケアの世界市場医薬品別推定・予測2019-2029
  • 女性用ヘルスケア市場、サブセグメント分析
    • プロリア
    • エクスジェバ
    • エビスタ
    • ミレーナ
    • ゾメタ
    • リクラスト
    • その他

第7章 女性用ヘルスケアの世界市場：用途別

  • マーケットスナップショット
  • 女性用ヘルスケアの世界市場：用途別、パフォーマンス- ポテンシャル分析
  • 女性用ヘルスケアの世界市場推定・予測（用途別） 2019-2029
  • 女性用ヘルスケア市場、サブセグメント分析
    • 女性不妊症
    • 閉経後骨粗鬆症
    • 子宮内膜症
    • 避妊
    • PCOS
    • 更年期

第8章 女性用ヘルスケアの世界市場：地域別分析

  • 女性用ヘルスケア市場、地域別市場スナップショット
  • 北米
    • 米国
      • 医薬品別の推定・予測、2019年～2029年
      • 用途別の推定・予測、2019年～2029年
    • カナダ
  • 欧州の女性用ヘルスケア市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋の女性用ヘルスケア市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの女性用ヘルスケア市場スナップショット
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ地域
  • 世界のその他の地域

第9章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • Bayer AG（Germany）
      • 主要な情報
      • 概要
      • 財務（データの入手が可能な場合のみ）
      • 製品概要
      • 最近の動向
    • Allergan plc（Dublin）
    • Merck & Co.（US）
    • Pfizer Inc.（US）
    • Amgen Inc.（US）
    • Agile Therapeutics Inc.（US）
    • Ferring Pharmaceuticals（US）
    • Mylan N.V.（US）
    • Lupin Limited（India）
    • Blairex Laboratories（US）

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査の特徴
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Womens Healthcare Market, report scope
  • TABLE 2. Global Womens Healthcare Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Womens Healthcare Market estimates & forecasts by Drug 2019-2029 (USD Billion)
  • TABLE 4. Global Womens Healthcare Market estimates & forecasts by Application 2019-2029 (USD Billion)
  • TABLE 5. Global Womens Healthcare Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Womens Healthcare Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Womens Healthcare Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Womens Healthcare Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Womens Healthcare Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Womens Healthcare Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Womens Healthcare Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Womens Healthcare Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Womens Healthcare Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Womens Healthcare Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Womens Healthcare Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Womens Healthcare Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Womens Healthcare Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Womens Healthcare Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Womens Healthcare Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Womens Healthcare Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Womens Healthcare Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Womens Healthcare Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Womens Healthcare Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Womens Healthcare Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Womens Healthcare Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Womens Healthcare Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Womens Healthcare Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Womens Healthcare Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Womens Healthcare Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Womens Healthcare Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Womens Healthcare Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Womens Healthcare Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Womens Healthcare Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain Womens Healthcare Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Womens Healthcare Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Womens Healthcare Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Womens Healthcare Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Womens Healthcare Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Womens Healthcare Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Womens Healthcare Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Womens Healthcare Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Womens Healthcare Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Womens Healthcare Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Womens Healthcare Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Womens Healthcare Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Womens Healthcare Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Womens Healthcare Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Womens Healthcare Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Womens Healthcare Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Womens Healthcare Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Womens Healthcare Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Womens Healthcare Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Womens Healthcare Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Womens Healthcare Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Womens Healthcare Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Womens Healthcare Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Womens Healthcare Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Womens Healthcare Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Womens Healthcare Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Womens Healthcare Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Womens Healthcare Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Womens Healthcare Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Womens Healthcare Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Womens Healthcare Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Womens Healthcare Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Womens Healthcare Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Womens Healthcare Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Womens Healthcare Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Womens Healthcare Market
  • TABLE 70. List of primary sources, used in the study of global Womens Healthcare Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Womens Healthcare Market, research methodology
  • FIG 2. Global Womens Healthcare Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Womens Healthcare Market, key trends 2021
  • FIG 5. Global Womens Healthcare Market, growth prospects 2022-2029
  • FIG 6. Global Womens Healthcare Market, porters 5 force model
  • FIG 7. Global Womens Healthcare Market, pest analysis
  • FIG 8. Global Womens Healthcare Market, value chain analysis
  • FIG 9. Global Womens Healthcare Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Womens Healthcare Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Womens Healthcare Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Womens Healthcare Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Womens Healthcare Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Womens Healthcare Market, regional snapshot 2019 & 2029
  • FIG 15. North America Womens Healthcare Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Womens Healthcare Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Womens Healthcare Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Womens Healthcare Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Womens Healthcare Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Womens Healthcare Market is valued approximately USD 12.30 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 13.2 % over the forecast period 2022-2029. Womens Healthcare defied as the branch of medicine that deals with the treatment and diagnosis of diseases and conditions that affect a woman's physical and emotional well-being. Women Healthcare include a wide range of focus areas including Birth control, sexually transmitted infections (STIs), breast cancer, ovarian cancer, Mammography, Menopause , Osteoporosis, Pregnancy and childbirth related issues, and Sexual health among others. The increasing incidence of chronic health conditions among women and growing popularity of contraceptive for preventing unintended pregnancy are key factors driving the market growth.

The increasing incidences of chronic health conditions among women population is contributing towards the growth of the Global Womens Healthcare Market. For instance - as per World Health organization estimates - as of 2020, globally around 48 million couples and 186 million individuals are affected by infertility . Additionally, according to a survey conducted by the National Survey of Family Growth (NSFG) around 15.5% of all women who intend to become pregnant are affected by infertility. Furthermore, rising consumption of contraceptive for mitigating undesired pregnancy is another factor driving the market space. For instance - according to World Health Organization (WHO) - as of 2020, Globally there were 851 million more women using modern methods of contraception than there were 663 million a two decade ago, and the prevalence rate rose from 47.7 to 49.0 percent. By 2030, an additional 70 million women are anticipated to join the population. Also, rising focus on new product development as well as initiatives from government authority to curb population growth would create lucrative growth prospects for the market over the forecast period. However, high Cost of Womens Healthcare products and lack of awareness in middle- and low-income regions hinders the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Womens Healthcare Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and the increasing prevalence of PCOS and postmenopausal osteoporosis, rising first-pregnancy median age, and growing healthcare costs in the US and Canada in the region. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising consumption of contraceptive drugs as well as increasing prevalence of chronic disease among women population in the region would offer lucrative opportunities for the market over the projected period. For instance - according to a survey conducted by the National Family Health Survey (NFHS) in 2021, in India the usage of contemporary contraceptives for family planning grew from 47.8% to 56.5% between the NFHS-4 (2015-16) and NHFS-5 (2019-20) surveys.

Major market players included in this report are:

  • Bayer AG (Germany)
  • Allergan plc (Dublin)
  • Merck & Co. (US)
  • Pfizer Inc. (US)
  • Amgen Inc. (US)
  • Agile Therapeutics Inc. (US)
  • Ferring Pharmaceuticals (US)
  • Mylan N.V. (US)
  • Lupin Limited (India)
  • Blairex Laboratories (US)

Recent Developments in the Market:

  • In April 2021, The FDA has approved the drug, which is a new combined oral contraceptive (COC) containing 3 mg drospirenone (DRSP) and 14.2 mg estetrol (E4). Mithra Pharmaceuticals created the first and only contraceptive pill containing E4. This is the first new oestrogen introduced in the United States in more than 50 years.
  • In July 2022, HRA Pharma, a French pharmaceutical company, has applied to the US Food and Drug Administration (FDA) for the first over-the-counter birth control pill in the country.

Global Womens Healthcare Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Drugs, Application, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drugs

  • Prolia
  • Xgeva
  • Evista
  • Mirena
  • Zometa
  • Reclast
  • Others

By Application

  • Female Infertility
  • Postmenopausal Osteoporosis
  • Endometriosis
  • Contraception
  • PCOS
  • Menopause

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Womens Healthcare Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Womens Healthcare Market, by Drug, 2019-2029 (USD Billion)
    • 1.2.3. Womens Healthcare Market, by Application, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Womens Healthcare Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Womens Healthcare Market Dynamics

  • 3.1. Womens Healthcare Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing incidence of chronic health conditions among women
      • 3.1.1.2. Growing popularity of contraceptive for preventing unintended pregnancy
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Womens Healthcare products
      • 3.1.2.2. Lack of awareness in middle- and low-income regions
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising focus on new product development
      • 3.1.3.2. Initiatives from government authority to curb population growth

Chapter 4. Global Womens Healthcare Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Womens Healthcare Market, by Drug

  • 6.1. Market Snapshot
  • 6.2. Global Womens Healthcare Market by Drug, Performance - Potential Analysis
  • 6.3. Global Womens Healthcare Market Estimates & Forecasts by Drug 2019-2029 (USD Billion)
  • 6.4. Womens Healthcare Market, Sub Segment Analysis
    • 6.4.1. Prolia
    • 6.4.2. Xgeva
    • 6.4.3. Evista
    • 6.4.4. Mirena
    • 6.4.5. Zometa
    • 6.4.6. Reclast
    • 6.4.7. Others

Chapter 7. Global Womens Healthcare Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Womens Healthcare Market by Application, Performance - Potential Analysis
  • 7.3. Global Womens Healthcare Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
  • 7.4. Womens Healthcare Market, Sub Segment Analysis
    • 7.4.1. Female Infertility
    • 7.4.2. Postmenopausal Osteoporosis
    • 7.4.3. Endometriosis
    • 7.4.4. Contraception
    • 7.4.5. PCOS
    • 7.4.6. Menopause

Chapter 8. Global Womens Healthcare Market, Regional Analysis

  • 8.1. Womens Healthcare Market, Regional Market Snapshot
  • 8.2. North America Womens Healthcare Market
    • 8.2.1. U.S. Womens Healthcare Market
      • 8.2.1.1. Drug breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. Application breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Womens Healthcare Market
  • 8.3. Europe Womens Healthcare Market Snapshot
    • 8.3.1. U.K. Womens Healthcare Market
    • 8.3.2. Germany Womens Healthcare Market
    • 8.3.3. France Womens Healthcare Market
    • 8.3.4. Spain Womens Healthcare Market
    • 8.3.5. Italy Womens Healthcare Market
    • 8.3.6. Rest of Europe Womens Healthcare Market
  • 8.4. Asia-Pacific Womens Healthcare Market Snapshot
    • 8.4.1. China Womens Healthcare Market
    • 8.4.2. India Womens Healthcare Market
    • 8.4.3. Japan Womens Healthcare Market
    • 8.4.4. Australia Womens Healthcare Market
    • 8.4.5. South Korea Womens Healthcare Market
    • 8.4.6. Rest of Asia Pacific Womens Healthcare Market
  • 8.5. Latin America Womens Healthcare Market Snapshot
    • 8.5.1. Brazil Womens Healthcare Market
    • 8.5.2. Mexico Womens Healthcare Market
    • 8.5.3. Rest of Latin America Womens Healthcare Market
  • 8.6. Rest of The World Womens Healthcare Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Bayer AG (Germany)
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Allergan plc (Dublin)
    • 9.2.3. Merck & Co. (US)
    • 9.2.4. Pfizer Inc. (US)
    • 9.2.5. Amgen Inc. (US)
    • 9.2.6. Agile Therapeutics Inc. (US)
    • 9.2.7. Ferring Pharmaceuticals (US)
    • 9.2.8. Mylan N.V. (US)
    • 9.2.9. Lupin Limited (India)
    • 9.2.10. Blairex Laboratories (US)

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption